Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Financial statements and analysis
Period names from company filings, with term end dates and filing dates
Income Statement (USD) Term End Date Filing Date | 2025 Dec 31, 2025 Mar 27, 2026 | 2024 Dec 31, 2024 Mar 27, 2026 |
|---|
Total Revenue | - | - |
Cost of Revenue | - | - |
Gross Profit | - | - |
Gross Margin % | - | - |
Research & Development | 18.43M 28.3% | 14.36M |
General & Administrative | 8.03M 33.0% | 6.04M |
Selling & Marketing | - | - |
SG&A Expenses | - | - |
Other Operating Expenses | - | - |
Total Operating Expenses | - | - |
Cost and Expenses | - | - |
Operating Income | -26.46M 29.7% | -20.40M |
Operating Margin % | - | - |
EBITDA | - | - |
EBITDA Margin % | - | - |
Interest Expense | - | - |
Interest Income | - | - |
Other Income (Expense) | - | - |
Pre-Tax Income | -24.70M 19.7% | -20.63M |
Pre-Tax Margin % | - | - |
Tax Provision | 172.00K | - |
Net Income | -24.87M 20.5% | -20.63M |
Net Margin % | - | - |
Basic EPS | -1.70 21.3% | -2.16 |
Diluted EPS | -1.70 21.3% | -2.16 |
Basic Shares Outstanding | 14.60M 52.6% | 9.56M |
Diluted Shares Outstanding | 14.60M 52.6% | 9.56M |